Therapy of pemphigus.
Bystryn
J C
JC
Department of Dermatology, New York University School of Medicine, New York 10016.
D018501:Antirheumatic Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003603:Cytotoxins / Q000627:therapeutic use; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D050607:Organogold Compounds; D010392:Pemphigus / Q000188:drug therapy / Q000628:therapy*; D010956:Plasmapheresis
D018501:Antirheumatic Agents; D003603:Cytotoxins; D050607:Organogold Compounds; D003622:Dapsone